Abstract 665: Discovery and Preclinical Characterization of PQR626: A Potent, Orally Available, and Brain-Penetrant Mtor Inhibitor for the Treatment of Tuberous Sclerosis Complex
Cancer research（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined